Astigmatism, Hyperopia, Myopia
Conditions
Brief summary
The aim of this trial is to assess Complete Easy Rub compared to a competitor multi-purpose solution in terms of lens cleanliness, subjective response and ocular response, when lenses are worn bilaterally on a daily wear basis for two months. The hypotheses for this trial are: * Lens cleanliness measures between solutions will be no different. * Subjective ratings between solutions will be no different. * Ocular response between solutions will be no different.
Interventions
DEVICEComplete Easy Rub Formula MPS
Multi-purpose solution
DEVICEAquify MPS
Multi-purpose solution
Sponsors
Abbott Medical Optics
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes
Inclusion criteria
* Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent; * Be at least 18 years old, male or female; * Willing to comply with the wearing and clinical trial visit schedule as directed by the investigator; * Have ocular health findings considered to be normal and which would not prevent the participant from safely wearing contact lenses; * Is correctable to at least 6/12 (20/40) or better in each eye with contact lenses; * Able to successfully wear one of the lens types to be used in this study on a daily wear (DW) basis in conjunction with any multi-purpose contact lens care solution (not including hydrogen peroxide-based systems) for at least one month prior to allocation of test or control solution;
Exclusion criteria
* Any pre-existing ocular irritation, injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses; * Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosus. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants; * Use of, or a need for, concurrent category S3 and above ocular medication at enrolment and/or during the study; * Use of, or a need for, any systemic medication or topical medications which may alter normal ocular findings/are known to affect a participant's ocular health/physiology or contact lens performance either in an adverse manner or beneficial manner at enrolment and/or during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of lens cleanliness of test and control solutions when used with soft lenses at the end of the manufacturer-recommended replacement interval. | Day 30 |
Outcome results
None listed